Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs eMed

CoreAge Rx
Graded #1

Higher grade

vs+34.4
eMed
Graded #398

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 57.4/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +47
92
45
Dose & formulationCoreAge Rx +48
88
40
Clinical oversightCoreAge Rx +10
93
83
Labs & monitoringCoreAge Rx +25
90
65
FulfillmentCoreAge Rx +33
95
62
Contract termsCoreAge Rx +41
96
55
CoreAge Rx · left bareMed · right bar

The numbers

MetricCoreAge RxeMed
WeighScore91.8/10057.4/100
GradeA−C
Scorecard rank#1#398
Semaglutide$149/moNot disclosed
Tirzepatide$349/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
eMed

Graded #398 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
  • At-home blood collection makes lab work convenient
  • Clinician review and ongoing side-effect plus adherence support
  • Works with CVS Caremark so eligible employees can buy through benefits
  • Established digital health company with national scale

Where it loses points

  • Distributed mainly via employers, with limited direct cash-pay access
  • No public transparent monthly price for individuals
  • Eligibility and subsidy depend on what the employer chooses to cover
  • Best suited to workforces, not casual self-pay shoppers

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard